Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Problems in coping with intractable bacterial infections]

H Goto1, K Shimada

  • 1Department of Pulmonary Diseases, Tokyo Metropolitan Komagome General Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A surgically treated case of ventrally exophytic pontine glioma].

No shinkei geka. Neurological surgery·1995
Same author

[Anomalous origin of the right pulmonary artery from the ascending aorta: a case report].

Kyobu geka. The Japanese journal of thoracic surgery·1995
Same author

Response of human gingival fibroblasts to prostaglandins.

Journal of periodontal research·1995
Same author

Hemodynamic effects of bolus nicorandil compared with nitroglycerin.

The American journal of emergency medicine·1995
Same author

Endovascular approach for an intracranial mycotic aneurysm associated with infective endocarditis.

The Journal of thoracic and cardiovascular surgery·1995
Same author

[Various immunoproliferative disorders].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·1995
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

New antimicrobials combat infections but fuel drug-resistant pathogens. This study examines challenges in treating chronic respiratory infections, focusing on identifying causative agents, bacterial flora dynamics, and Pseudomonas aeruginosa protease roles.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Antimicrobial drug development has reduced many bacterial infections.
  • However, this success has led to an increase in drug-resistant pathogens, like methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Mycobacterium tuberculosis (MDR-TB).
  • Intractable infections caused by these resistant strains pose significant global health challenges.

Purpose of the Study:

  • To outline the key problems in managing intractable bacterial infections.
  • To use chronic respiratory tract infections as a model to illustrate these challenges.
  • To highlight specific issues including pathogen identification, bacterial flora shifts, and virulence factors.

Main Methods:

  • Literature review and case study analysis of chronic respiratory tract infections.

Related Experiment Videos

  • Examination of diagnostic challenges in determining causative bacterial agents.
  • Analysis of bacterial community dynamics during infection.
  • Investigation into the pathogenic mechanisms of Pseudomonas aeruginosa extracellular proteases.

    • Main Results:

    • Effective identification of causative agents is crucial but often difficult in complex infections.
    • Understanding the dynamic shifts in bacterial flora is essential for effective treatment strategies.
    • Extracellular proteases from Pseudomonas aeruginosa play a significant role in disease progression and pathogenicity.

    Conclusions:

    • Addressing drug-resistant bacterial infections requires a multi-faceted approach.
    • Improved diagnostic methods for pathogen identification are needed.
    • Further research into bacterial flora dynamics and virulence factors, such as Pseudomonas aeruginosa proteases, is vital for developing new therapeutic strategies.